Leerink Partners Begins Coverage on ABT

By Yahoo! Finance   |   2 weeks ago
Leerink Partners Begins Coverage on ABT

Abbott Laboratories is a Dividend King with 53 years of dividend growth. Leerink Partners initiated coverage with a target price of $143, indicating a slight upside. The company recently gained approval for a rapid blood test in Canada.

Read More

Did you find this insightful?